Genentech's ranibizumab injection (Susvimo) has received FDA approval for the treatment of diabetic retinopathy. The ...

If you care about diabetes, please read studies about Vitamin D and type 2 diabetes, and to people with diabetes, some fruits ...

The Food and Drug Administration (FDA) has approved Susvimo ® (ranibizumab injection) for the treatment of patients with ...

Retinal drugs market growth driven by aging population, rising AMD prevalence, and advances in ophthalmic drug delivery and retinal disease treatment innovation.

India faces a growing crisis as childhood obesity rates rise sharply, increasing risks of diabetes and vision problems. Is CBSE's sugar board initiative enough to protect children's health?

Telangiectatic capillaries may have potential clinical relevance for diagnosis and treatment of diabetic macular edema.

Type 2 Diabetes Mellitus (T2DM) with Asthma is associated with an increase in severity of respiratory failure and more ...

Thanks to advancements in early detection and treatment options, it's possible to live a long and healthy life after being ...

Fear is a natural response when something threatens your vision—but it’s also a signal to act quickly. Some retinal ...

The FDA approved Susvimo 100 mg/mL to treat diabetic retinopathy, according to a press release from Genentech.The approval was supported by positive 1-year data from the phase 3 Pavilion study in ...

Susvimo is also approved to treat diabetic macular edema and age-related macular degeneration, and the medication, ...

Susvimo is the first and only FDA-approved, continuous delivery treatment shown to maintain vision in people with DR with ...